首页> 美国卫生研究院文献>Internal Medicine >An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients

【2h】

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients

机译：阿达木单抗治疗的类风湿关节炎患者的改善生物疾病的抗风湿药物的病情分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives The present study was performed with the aim of analyzing the biological disease-modifying antirheumatic drug (bDMARD)-free (Bio-free) condition of adalimumab (ADA)-treated rheumatoid arthritis (RA) patients in a real-world setting.

机译：目的进行本研究的目的是在现实环境中分析经阿达木单抗（ADA）治疗的类风湿关节炎（RA）患者的无生物疾病修饰抗风湿药（bDMARD）（Bio-free）状况。

著录项

期刊名称 Internal Medicine
作者
Satoshi Ito; Daisuke Kobayashi; Eriko Hasegawa; Chinatsu Takai; Tetsuya Nemoto; Hyunho Lee; Asami Abe; Hiroshi Otani; Hajime Ishikawa; Akira Murasawa; Ichiei Narita; Kiyoshi Nakazono;
展开▼
作者单位

展开▼
年(卷),期 2019(58),4
年度 2019
页码 511–519
总页数 9
原文格式 PDF
正文语种
中图分类基础医学;
关键词
rheumatoid arthritis adalimumab methotrexate conventional synthetic disease-modifying antirheumatic drugs biologics free condition;

机译：类风湿关节炎;阿达木单抗;甲氨蝶呤;常规合成抗病风湿药;无生物制剂;

相似文献

外文文献
中文文献
专利

1. Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study [J] . Motomu Hashimoto, Moritoshi Furu, Wararu Yamamoto, Arthritis research & therapy. . 2018,第1期

机译：类风湿关节炎中改善生物疾病的抗风湿药无药缓解相关因素：ANSWER队列研究
2. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan- European TOCERRA register collaboration [J] . Lauper Kim, Nordstrom Dan C., Pavelka Karel, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2018,第9期

机译：与TNF抑制剂与TNF抑制剂的比较有效性作为单药治疗或与常规的合成疾病改性抗逆素药物在使用至少一种生物学疾病改性的抗腹性药物后用类风湿性关节炎患者：从泛欧托拉登记协作分析
3. Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis. [J] . Salliot C, Finckh A, Katchamart W, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2011,第2期

机译：生物抗风湿药在类风湿关节炎中对常规疾病缓解性抗风湿药或抗肿瘤坏死因子药物反应不足的患者的间接比较：一项荟萃分析。
4. Immunogenic HLA-DR-presented-peptides Identified from Clinical Samples of Synovial Tissue/Fluid and Peripheral Blood from Patients with Rheumatoid Arthritis or Lyme Arthritis [C] . Qi Wang, Elise E. Drouin, Chunxiang Yao, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：免疫原性HLA-DR呈递肽，从类风湿性关节炎或莱姆关节炎患者的滑膜组织/液体和外周血的临床样本中鉴定出来
5. “Don’t Rock the Boat”: A Qualitative Narrative Study Exploring Rheumatoid Arthritis Patients’ Experience of Illness and Biologics [D] . Rachich, Meagan . 2020

机译：“不要摇滚船”：探索类风湿性关节炎患者的疾病和生物学经验的定性叙事研究
6. Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study [O] . Motomu Hashimoto, Moritoshi Furu, Wararu Yamamoto, 2018

机译：类风湿关节炎中改善生物疾病的抗风湿药无药缓解相关因素：ANSWER队列研究
7. An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients [O] . Satoshi Ito, Daisuke Kobayashi, Eriko Hasegawa, 2019

机译：抗原毒性型类风湿性关节炎患者的生物疾病改性抗抗药性病症分析

An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients

摘要

著录项

相似文献

相关主题

期刊订阅